An in situ synthesis of mesoporous SBA-16/hydroxyapatite for ciprofloxacin release: in vitro stability and cytocompatibility studies

Journal of Materials Science: Materials in Medicine

Volumn 25, Issue 11, 2014, Pages 2527-2540

  Andrade, Gracielle Ferreira ^a,b   Gomide, Viviane Silva ^a   da Silva Júnior, Armando Cunha ^b   Goes, Alfredo Miranda ^b   de Sousa, Edésia Martins Barros ^a  

^a CENTRO DE DESENVOLVIMENTO DA TECNOLOGIA NUCLEAR   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; ANTIBIOTICS; ASSAYS; BEHAVIORAL RESEARCH; BONE; CELL CULTURE; CELL ENGINEERING; DRUG DELIVERY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GAS ADSORPTION; PHOSPHATASES; REPAIR; SCAFFOLDS (BIOLOGY); SCANNING ELECTRON MICROSCOPY; STEM CELLS; TISSUE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; X RAY SCATTERING;

ALKALINE PHOSPHATASE ACTIVITY; DRUG DELIVERY SYSTEM; HUMAN ADIPOSE TISSUE; INTRINSIC CHARACTERISTICS; MESENCHYMAL STEM CELL; MESOPOROUS STRUCTURES; SMALL ANGLE X-RAY SCATTERING; SURFACE INTERACTIONS;

MESOPOROUS MATERIALS;

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; CIPROFLOXACIN; DRUG CARRIER; HYDROXYAPATITE; SBA 16; SILICON DIOXIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION; SBA-16;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; BONE REMODELING; CELL VIABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MTT ASSAY; SCANNING ELECTRON MICROSCOPY; STEM CELL; TISSUE ENGINEERING; TRANSMISSION ELECTRON MICROSCOPY; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION; ABSORPTION; ADMINISTRATION AND DOSAGE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG EFFECTS; DRUG STABILITY; MESENCHYMAL STROMA CELL; PHYSIOLOGY; POROSITY;

ABSORPTION, PHYSICOCHEMICAL; ANTI-BACTERIAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; CIPROFLOXACIN; DELAYED-ACTION PREPARATIONS; DIFFUSION; DRUG STABILITY; DURAPATITE; HUMANS; MESENCHYMAL STROMAL CELLS; POROSITY; SILICON DIOXIDE;

EID: 84910151233     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-014-5273-6     Document Type: Article

References (46)

1. Arcos D, Vallet-Regí M. Sol–gel silica-based biomaterials and bone tissue regeneration. Acta Biomater. 2010;6:2874–88.
2. Hu Y, Wang J, Zhi Z, Jiang T, Wang S. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug. J Colloid Interface Sci. 2011;363:410–7.
3. Zhao D, Feng J, Huo Q, Melosh N, Fredrickson GH, Chmelka BF, Stucky GD. Triblock copolymer synthesis of mesoporous silica with periodic 50–300 angstrom pores. Science. 1998;279:548–52.
4. Zhao D, Huo Q, Feng J, Chmelka BF, Stucky GD. Nonionic triblock and star diblock copolymer and oligomeric surfactant synthesis of highly ordered, hydrothermally stable, mesoporous silica structures. J Am Chem Soc. 1998;120:6024–36.
5. Hu Y, Zhi Z, Zhao Q, Wu C, Zhao P, Jiang H, Jiang T, Wang S. 3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol. Microporous Mesoporous Mater. 2012;147:94–101.
6. Wang P, Zhu Y, Yang X, Li C, Du HL. Synthesis of CdSe nanoparticles into the pores of mesoporous silica microspheres. Acta Mater. 2008;56:1144–50.
7. Doadrio JC, Sousa EMB, Izquierdo-Barba I, Doadrio AL, Perez-Pariente J, Vallet-Regí M. Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J Mater Chem. 2006;16:462–6.
8. Meng, et al. Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano. 2013;7:994–1005.
9. Zhang Y, Zhang M. Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release. J Biomed Mater Res. 2002;62:378–86.
10. Dìaz A, Lopez T, Manjarrez J, Basaldella E, Martìnez-Blanes JM, Odriozola JA. Growth of hydroxyapatite in a biocompatibilite mesoporous ordered silica. Acta Biomater. 2006;2:173–9.
11. Vallet-Regí M, Balas F. Silica materials for medical applications. Open Biomed Eng J. 2008;2:1–9.
12. Cornell CN, Lane JM. Newest factors in fracture healing. Clin Orthop. 1992;2(77):297–311.
13. Yang Z, Yuan H, Tong W, Zou P, Chen W, Zhang X. Osteogenesis in extraskeletally implanted porous calcium phosphate ceramics: variability among different kinds of animal. Biomaterials. 1996;17:2131–7.
14. Andersson J, Areva S, Spliethoff B, Lindén M. Sol–gel synthesis of a multifunctional, hierarchically porous silica/apatite composite. Biomaterials. 2005;26:6827–35.
15. Sousa EMB, Souza KC, Sousa A. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery. Acta Biomater. 2008;4:671–9.
16. Fan W, Wu C, Han P, Zhou Y, Xiao Y. Porous Ca–Si-based nanospheres: a potential intra-canal disinfectant-carrier for infected canal treatment. Mater Lett. 2012;81:16–9.
17. Xia Z, Liao L, Zhao S. Synthesis of mesoporous hydroxyapatite using a modified hard-templating route. Mater Res Bull. 2009;44:1626–9.
18. Bellah M M, Christensen S M, Iqbal S M. Nanostructures for Medical Diagnostics. J Nano Mat. 2012. doi:10.1155/2012/486301.
19. Elsaesser A, Howard CV. Toxicology of nanoparticles. Adv Drug Deliv Rev. 2012;64:129–37.
20. Gobin O S. SBA-16 materials synthesis, diffusion and sorption properties. Ph.D thesis, Laval University: Ste-Foy, Quebec, Canada; 2006.
21. Ehlert N, Badar M, Christel A, Lohmeier JS, Luessenhop T, Stieve M, Lenarz T, Muellerb PP, Behrens P. Mesoporous silica coatings for controlled release of the antibiotic ciprofloxacin from implants. J Mater Chem. 2011;21:752–60.
22. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Lorenz BP, Peter H, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211–28.
23. Shi X, Wang Y, Wei K, Ren L, Lai C. Self-assembly of nanohydroxyapatite in mesoporous silica. J Mater Sci Mater Med. 2008;19:2933–40. doi:10.1007/s10856-008-3424-3.
24. Zyman Z, Rokhmistrov D, Glushko V. Structural changes in precipitates and cell model for the conversion of amorphous calcium phosphate to hydroxyapatite during the initial stage of precipitation. J Cryst Growth. 2012;353:5–11.
25. Fathi MH, Hanifi A. Evaluation and characterization of nanostructure hydroxyapatite powder prepared by a simple sol–gel method. Mater Lett. 2007;61:3978–83.
26. x/SBA-16 mesoporous catalyst for hydroxylation of benzene. Chin J Catal. 2008;29:1067–9.
27. Sakamoto Y, Kaneda M, Terasaki O, Zhao DY, Kim JM, Stucky G, Shim HJ, Ryoo R. Direct imaging of the pores and cages of three-dimensional mesoporous materials. Nature. 2000;408:449–53.
28. Cheng C, Lin Y, Cheng H, Chen Y. The effect and model of silica concentrations on physical properties and particle sizes of three-dimensional SBA-16 nanoporous materials. Chem Phys Lett. 2003;382:496–501.
29. Wang L, Fan J, Tian B, Yang H, Yu C, Tu B, Zhao D. Synthesis and characterization of small pore thick-walled SBA-16 templated by oligomeric surfactant with ultra-long hydrophilic chains. Microporous Mesoporous Mater. 2004;67:135–41.
30. Désévaux C, Lenaerts V, Girard C, Dubreuil P. Characterization of crosslinked high amylose starch matrix implants 2. In vivo release of ciprofloxacin. J Control Release. 2002;82:95–103.
31. Kayser FH, Eberle H. Local antibiotic treatment in osteomyelitis and soft tissue infections: proceeding of symposium. In:Th JG van Rens, F H Kayser, editors. Amsterdam: Excerpta Medica; 1981. 196 p. 1–7.
32. Babić S, Horvat AJM, Pavlović DM, Kaštelan-Macan M. Determination of pKa values of active pharmaceutical ingredients. Trends Anal Chem. 2007;26:1–19.
33. Fisichella M, Dabboue M, Bhattacharyya S, Saboungi ML, Salvetat JP, Hevor T, Guerin M. Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol In Vitro. 2009;23:697–703.
34. Lai C, Trewyn BG, Jeftinija DM, Jeftinija K, Xu S, Jeftinija S, Lin VSY. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc. 2003;125:4451–9.
35. Giri S, Trewyn BG, Stellmaker MP, Lin VS. Stimuli-responsive controlledrelease delivery system based on mesoporous silica nanorods capped with magnetic nanoparticles. Angew Chem Int Ed Engl. 2005;44:5038–44.
36. Huang D, et al. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. FASEB J. 2005;19:2014–6.
37. Lin Y-S, Tsai C-P, Huang H-Y, Kuo C-T, Hung Y, Huang D-M, Chen Y-C, Mou C-Y. Well-ordered mesoporous silica nanoparticles as cell markers. Chem Mater. 2005;17:4570–3.
38. Slowing I, Trewyn BG, Lin VSY. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc. 2006;128:14792–3.
39. Chung TH, Wu SH, Yao M, Lu CW, Lin YS, Hung Y, Mou CY, Chen YC, Huang DM. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles 3T3–L1 cells and human mesenchymal stem cells. Biomaterials. 2007;28:2959–66.
40. Berridge MV, Herst PM, Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev. 2005;11:127–52.
41. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
42. Tao ZM, Morrow MP, Asefa T, Sharma KK, Duncan C, Anan A, Penefsky HS, Goodisman J, Souid AK. Mesoporous silica nanoparticles inhibit cellular respiration. Nano Lett. 2008;8:1517–26.
43. Brown SC, Kamal M, Nasreen N, Baumuratov A, Sharma P, Antony VB, Moudgil BM. Influence of shape, adhesion and simulated lung mechanics on amorphous silica nanoparticle toxicity. Adv Powder Technol. 2007;18:69–79.
44. Bosetti M, Zanardi L, Hench L, Cannas M. Type I collagen production by osteoblast-like cells cultured in contact with different bioactive glasses. J Biomed Mater Res A. 2003;64:189–95.
45. Radin S, Reilly G, Bhargave G, Leboy PS, Ducheyne P. Osteogenic effects of bioactive glass on bone marrow stromal cells. J Biomed Mater Res A. 2005;73:21–9.
46. Bosetti M, Cannas M. The effect of bioactive glasses on bone marrow stromal cells differentiation. Biomaterials. 2005;26:3873–9.